Cigna Group Croissance future

Future contrôle des critères 3/6

Cigna Group devrait augmenter ses bénéfices et son chiffre d'affaires de 24.4% et de 5.5% par an respectivement. Le BPA devrait croître de de 29.5% par an. Le rendement des capitaux propres devrait être 19.3% dans 3 ans.

Informations clés

24.4%

Taux de croissance des bénéfices

29.5%

Taux de croissance du BPA

Healthcare croissance des bénéfices	21.1%
Taux de croissance des recettes	5.5%
Rendement futur des capitaux propres	19.3%
Couverture par les analystes	Good
Dernière mise à jour	18 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well

Oct 14

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

Apr 18

Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why

Apr 09

Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Apr 05

Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018

Apr 01

Cigna: Trimming The Fat And Staying Focused

Mar 05

Cigna: Big Buybacks And Total Return Potential

Feb 26

Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40

Feb 05

Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap

Jan 29

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

Jan 25

Why Dividend Growth Investors Should Buy Cigna

Jan 18

It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)

Jan 09

Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital

Dec 25

Cigna: Sentiment And Fundamentals On Their Side

Dec 21

Cigna's Merger Fumble: A Festive Financial Rebound

Dec 11

Humana And Cigna Topple On Rumors Of An Unlikely Union

Nov 30

Cigna Delivering Growth At A Great Price

Nov 13

Cigna: Too Cheap To Ignore

Oct 24

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

Oct 06

Cigna: Buy Rating Driven By Undervaluation & Revenue Growth

Oct 01

Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return

Sep 21

Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape

Sep 14

Cigna Group: Weaker Than Peers But Still A Buy

Aug 27

Cigna: Buy During The Next Correction (Technical Analysis)

Aug 08

Cigna Group (NYSE:CI) Has A Pretty Healthy Balance Sheet

Jul 02

Cigna: Buy While It's Still Cheap And Not Loved

Jun 29

If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity

Jun 18

Cigna: Buy This Value Gem Before It Bounces Back

Jun 12

Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture

Jun 04

Prévisions de croissance des bénéfices et des revenus

NYSE:CI - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	265,379	7,367	12,157	12,780	17
12/31/2025	251,877	7,064	11,356	11,986	18
12/31/2024	243,995	3,866	12,185	11,051	14
9/30/2024	229,747	3,039	5,184	6,618	N/A
6/30/2024	216,008	3,708	7,960	9,398	N/A
3/31/2024	204,145	3,620	10,160	11,625	N/A
12/31/2023	195,187	5,164	10,240	11,813	N/A
9/30/2023	189,866	5,328	10,892	12,445	N/A
6/30/2023	186,031	6,677	11,414	12,902	N/A
3/31/2023	182,808	6,774	10,239	11,654	N/A
12/31/2022	180,031	6,704	7,361	8,656	N/A
9/30/2022	180,028	6,627	9,578	10,832	N/A
6/30/2022	179,185	5,491	8,402	9,668	N/A
3/31/2022	176,986	5,401	6,928	8,128	N/A
12/31/2021	174,267	5,370	6,037	7,191	N/A
9/30/2021	170,397	8,384	6,041	7,210	N/A
6/30/2021	167,028	8,151	4,915	5,986	N/A
3/31/2021	163,141	8,438	8,487	9,556	N/A
12/31/2020	160,550	8,458	9,256	10,350	N/A
9/30/2020	157,009	5,300	7,764	8,849	N/A
6/30/2020	154,629	5,263	9,339	10,415	N/A
3/31/2020	154,168	4,917	7,057	8,180	N/A
12/31/2019	153,743	5,104	8,435	9,485	N/A
9/30/2019	129,660	4,271	5,896	6,818	N/A
6/30/2019	102,510	3,692	4,176	4,981	N/A
3/31/2019	75,145	3,090	4,318	4,937	N/A
12/31/2018	48,569	2,637	3,242	3,770	N/A
9/30/2018	44,969	2,759	3,742	4,219	N/A
6/30/2018	44,001	2,547	N/A	4,830	N/A
3/31/2018	42,949	2,554	N/A	4,532	N/A
12/31/2017	42,043	2,237	N/A	4,086	N/A
9/30/2017	41,332	2,353	N/A	4,358	N/A
6/30/2017	40,723	2,249	N/A	5,035	N/A
3/31/2017	40,258	1,946	N/A	4,684	N/A
12/31/2016	40,007	1,867	N/A	4,026	N/A
9/30/2016	39,252	1,911	N/A	4,315	N/A
6/30/2016	38,761	2,002	N/A	3,017	N/A
3/31/2016	38,293	2,080	N/A	3,117	N/A
12/31/2015	37,876	2,094	N/A	2,933	N/A
9/30/2015	37,276	2,135	N/A	2,319	N/A
6/30/2015	36,644	2,122	N/A	2,175	N/A
3/31/2015	35,885	2,107	N/A	2,241	N/A
12/31/2014	34,914	2,102	N/A	2,158	N/A
9/30/2014	34,098	1,996	N/A	2,084	N/A
6/30/2014	33,407	2,015	N/A	2,444	N/A
3/31/2014	32,654	1,947	N/A	2,014	N/A
12/31/2013	32,380	1,476	N/A	719	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CI ( 24.4% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de CI ( 24.4% par an) devraient croître plus rapidement que le marché US ( 15.3% par an).

Croissance élevée des bénéfices: Les bénéfices de CI devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de CI ( 5.5% par an) devrait croître plus lentement que le marché de US ( 8.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de CI ( 5.5% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de CI devrait être faible dans 3 ans ( 19.3 %).

Cigna Group Croissance future

Future contrôle des critères 3/6

Informations clés

Mises à jour récentes de la croissance future

Consensus EPS estimates fall by 17%, revenue upgraded

Consensus EPS estimates fall by 16%

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

Recent updates

Biohealth Medical Laboratory, Inc. and PB Laboratories, LLC Provides an Legal Update

Biohealth Medical Laboratory, Inc. and PB Laboratories, LLC Provides an Legal Update

Consensus EPS estimates fall by 17%, revenue upgraded

New major risk - Financial position

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Second quarter dividend of US$1.40 announced

These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well

Insufficient new directors

Cigna Healthcare Offers Medicare Customers Value, Stability and Choice with 2025 Plans

Cigna: This Dividend Grower Could Be Worth Buying Now

Returns On Capital Are Showing Encouraging Signs At Cigna Group (NYSE:CI)

Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'

The Price Is Right For The Cigna Group (NYSE:CI)

Upcoming dividend of US$1.40 per share

Executive VP notifies of intention to sell stock

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Cigna Group: Services Focus Leads To Outperformance

First quarter dividend of US$1.40 announced

The Cigna Group Declares Quarterly Dividend, Payable on September 19, 2024

Cigna: Game Over For PBMs?

Executive VP notifies of intention to sell stock

Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet

Cigna: Will Benefit From Lower Medicaid Enrollments

Upcoming dividend of US$1.40 per share

The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing

The Cigna Group to Report Q3, 2024 Results on Oct 31, 2024

Insider notifies of intention to sell stock

Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now

Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

Consensus EPS estimates fall by 16%

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Fourth quarter dividend of US$1.40 announced

The Cigna Group Declares Quarterly Dividend, Payable on June 20, 2024

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

National Center for Public Files an Exempt Solicitation Statement and Request Vote for the Proposal

Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why

Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018

President notifies of intention to sell stock

The Cigna Group, Annual General Meeting, Apr 24, 2024

Cigna: Trimming The Fat And Staying Focused

Upcoming dividend of US$1.40 per share

Cigna: Big Buybacks And Total Return Potential

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40

Third quarter dividend increased to US$1.40

Insider notifies of intention to sell stock

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

The Cigna Group Declares Cash Quarterly Dividend, Payable on March 21, 2024

Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

the Cigna Group Announces Intention to Retire of Mary Agoglia Hoeltzel as Senior Vice President and Chief Accounting Officer, Effective from July 1, 2024

Why Dividend Growth Investors Should Buy Cigna

The Cigna Group Announces Management Changes

It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)

Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital

Cigna: Sentiment And Fundamentals On Their Side

Insider notifies of intention to sell stock

Investor sentiment improves as stock rises 17%

Cigna's Merger Fumble: A Festive Financial Rebound

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana And Cigna Topple On Rumors Of An Unlikely Union

Cigna and Humana Reportedly in Merger Talks

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Upcoming dividend of US$1.23 per share at 1.7% yield

The Cigna Group to Report Q2, 2024 Results on Aug 01, 2024

Cigna Delivering Growth At A Great Price

Cigna Reportedly Explores Shedding Medicare Advantage Business

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Cigna Group Declares Quarterly Dividend, Payable on December 21, 2023